Phosphorus (P) is vital for plant growth, but its agricultural use is limited by soil fixation and environmental loss. This study developed an organic ligand-responsive phosphate release system by hybridizing magnesium-iron-layered double hydroxides (Mg-Fe LDH) with pectin from apple and citrus (pectin-A/C). Structural properties and phosphate (PO) release of LDH hybrids with different concentrations of metal precursors (0.5LDH-A/C, 2.5LDH-A/C) were evaluated. All hybrids exhibited higher PO sorption than pristine Mg-Fe LDH, with 2.5LDH-A reaching 118.2 mg g. Phosphate release kinetics showed that 0.5LDH-A/C provided slow release up to 1056 h, while 2.5LDH-A/C released 87.7% PO with 4 mM citrate, responding to organic ligands. Synchrotron spectroscopy revealed that Fe substitution in LDH layers and Fe(III)-P species was the key influencing PO release. The slow-release behavior of 0.5LDH-A/C and the ligand responsiveness of 2.5LDH-A/C highlight their potential to enhance sustainable agriculture by improving fertilizer efficiency, ensuring food security, and minimizing environmental impact.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/acs.jafc.4c12454 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Hybridizing Mg-Fe Layered Double Hydroxide with Pectin Natural Polymer for Organic Ligand-Responsive Phosphate Release: An Innovative Controlled-Release Phosphorus Fertilizer.
J Agric Food Chem
March 2025
Department of Soil and Environmental Sciences, National Chung Hsing University, 145 Xingda Rd., Taichung 40227, Taiwan.
Phosphorus (P) is vital for plant growth, but its agricultural use is limited by soil fixation and environmental loss. This study developed an organic ligand-responsive phosphate release system by hybridizing magnesium-iron-layered double hydroxides (Mg-Fe LDH) with pectin from apple and citrus (pectin-A/C). Structural properties and phosphate (PO) release of LDH hybrids with different concentrations of metal precursors (0.
View Article and Find Full Text PDFPioneering Clinical Investigation: Beta Defensin Expression in Patients of Squamous Cell Carcinoma of Oral Cavity as a Forward-Looking Validation for Molecular Treatment.
Indian J Otolaryngol Head Neck Surg
January 2025
Department of Otorhinolaryngology, All India Institute of Medical Sciences Jodhpur, Jodhpur, Rajasthan 342005 India.
Human defensins are peptides coded by certain genes released as a part of immune response that act differently to tumorigenic cells according to the class. A varied cellular response has been documented in the world literature concerning the role of defensins in the cancer cell lines, though the exact role in the internal human milieu and the role specific to head and neck cancers is still understudied. This study explores the possible role of Human Beta Defensin (HBD) 1 and 3 in head and neck squamous cell carcinoma in disease progression and their potential as biomarkers/prognostic markers.
View Article and Find Full Text PDFThe conformational landscape of TRiC ring-opening and its underlying stepwise mechanism revealed by cryo-EM.
QRB Discov
December 2024
Key Laboratory of RNA Innovation, Science and Engineering, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, China.
The TRiC/CCT complex assists in the folding of approximately 10% of cytosolic proteins through an ATP-driven conformational cycle, playing a crucial role in maintaining protein homeostasis. Despite our understanding of ATP-driven TRiC ring closing and substrate folding, the process and mechanisms underlying TRiC ring-opening and substrate release remain largely unexplored. In this study, by determining an ensemble of cryo-EM structures of yeast TRiC in the presence of ADP, including three intermediate transition states, we present a comprehensive picture of the TRiC ring-opening process.
View Article and Find Full Text PDFIn Vitro-In Vivo Correlation Of Amorphous Solid Dispersion Enabled Itraconazole Tablets.
Pharm Res
March 2025
Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 Penn Street, Room 623, HSF2 Building, Baltimore, MD, 21201, USA.
Purpose: There are scarce reports on in vitro-in vivo correlation (IVIVC) model development of immediate-release (IR) formulations, and few investigations of the impacts of formulation and process of spray-dried solid dispersions (SDD)-based tablets on human pharmacokinetics (PK), despite commercial product successes. The goal of this study was to investigate the formulation and process factors that impact bioavailability enhancement of IR itraconazole SDD tablets; and to develop an FDA level A IVIVC that would predict in vivo PK performance from in vitro dissolution testing.
Methods: A direct, differential-equation-based IVIVC model approach was employed, using an oral solution for post-dissolution disposition and Fast-, Medium-, and Slow-release tablets.
Enhancing Drug Release from PEG-PLGA Implants: The Role of Hydrophilic Dexamethasone Phosphate in Modulating Release Kinetics and Degradation Behavior.
Eur J Pharm Sci
March 2025
Institute of Pharmacy, Martin Luther University Halle-Wittenberg, Wolfgang-Langenbeck-Straße 4, 06120 Halle (Saale), Germany; Halle Research Centre for Drug Therapy (HRCDT), Halle (Saale), Germany. Electronic address:
Poly(lactic-co-glycolic acid) (PLGA) is a prominent biodegradable polymer used in biomedical applications, including drug delivery systems (DDS) and tissue engineering. PLGA's ability to control drug release is often hindered by nonlinear release profiles and slow initial drug release for hydrophobic drugs. This study investigates the incorporation of dexamethasone phosphate (DEXP) into polyethylene glycol-poly(lactic-co-glycolic acid) (PEG-PLGA) implants to enhance the initial release rate of dexamethasone (DEX).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!